Assay Detail
Binding
CHEMBL5734141
Review assay metadata, readout intent, target linkage, and publication context from the same page.
Biochemical Assay: I. Compound handling: Testing compounds were dissolved in 100% DMSO to a specific concentration. The serial dilution was conducted by epMotion 5070 in DMSO. II. HDAC reaction buffer: 50 mM Tris-HCl, pH8.0, 137 mM NaCl, 2.7 mM KCl, and 1 mM MgCl2, Added fresh: 1 mg/ml BSA, 1% DMSO. III. Substrate: Fluorogenic HDAC General Substrate for HDAC1, 2, 3, 6, 10, 11 ans Sirt1, 2 and 3: Arg-His-Lys-Lys(Ac); HDAC8 only substrate: Arg-His-Lys(Ac)-Lys(Ac); Class2A Substrate (HDAC4, 5, 7 and 9): Acetyl-Lys(trifluoroacetyl)-AMC; Sirt5 substrate: Ac-Lys(succinyl)-AMC. IV. General Reaction Procedure: (Standard IC50 determination) a. Delivered 2× enzyme in wells of reaction plate except No Enzyme (No En) control wells. Add buffer in No En wells. b. Delivered compounds in 100% DMSO into the enzyme mixture by Acoustic technology (Echo550; nanoliter range). Spin down and pre-incubation. c. Delivered 2× Substrate Mixture (Fluorogenic HDAC Substrate and co-factor (500 μM of Nicotinamide adenine dinucleotide (NAD+) in all Sirt assay) in all reaction wells to initiate the reaction. Spin and shake. d. Incubated for 1-2 hr. at 30° C. with seal. e. Added Developer with Trichostatin A (or TMP269 or NAD+) to stop the reaction and to generate fluorescent color. f. Fluorescence was read (excitatory, 360; emission, 460) using the EnVision Multilabel Plate Reader (Perkin Elmer) g. Endpoint reading was taken for analysis after the development reaches plateau. V. Data Analysis: The percentages of enzyme activity (relative to DMSO controls) and IC50 values were calculated using the GraphPad Prism 4 program based on a sigmoidal dose-response equation.
12
Total Activities
4
Compounds Tested
3
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Confidence | 9 — Direct single protein target |
| Curated By | Autocuration |
Publication
Histone deacetylase inhibitors and methods for use thereof
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| IC50 | 4 | 5.96 | 7.18 |
| kon | 4 | - | - |
| k_off | 4 | - | - |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL3110004 | — | — | 3 | 7.18 |
| CHEMBL6011678 | — | — | 3 | 6.29 |
| CHEMBL99 | TRICHOSTATIN | 1.0 | 3 | 5.45 |
| CHEMBL98 | VORINOSTAT | 4.0 | 3 | 4.91 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL3110004 | — | IC50 | = | 65.7 | nM | 7.18 |
| CHEMBL6011678 | — | IC50 | = | 508.0 | nM | 6.29 |
| CHEMBL99 | TRICHOSTATIN | IC50 | = | 3530.0 | nM | 5.45 |
| CHEMBL98 | VORINOSTAT | IC50 | = | 12200.0 | nM | 4.91 |
| CHEMBL6011678 | — | kon | = | - | — | - |
| CHEMBL6011678 | — | k_off | = | - | s-1 | - |
| CHEMBL99 | TRICHOSTATIN | kon | = | - | — | - |
| CHEMBL99 | TRICHOSTATIN | k_off | = | - | s-1 | - |
| CHEMBL98 | VORINOSTAT | kon | = | - | — | - |
| CHEMBL98 | VORINOSTAT | k_off | = | - | s-1 | - |
| CHEMBL3110004 | — | kon | = | - | — | - |
| CHEMBL3110004 | — | k_off | = | - | s-1 | - |